AtaiBeckley (ATAI) Total Non-Current Liabilities (2020 - 2026)
AtaiBeckley's (ATAI) quarterly Total Non-Current Liabilities came in at $897000.0 in Q1 2026.
AtaiBeckley (ATAI) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
AtaiBeckley (ATAI) has 6 years of Total Non-Current Liabilities data on file, last reported at $908000.0 in Q3 2025.
- For the quarter ending Q3 2025, Total Non-Current Liabilities fell 97.88% year-over-year to $908000.0; the trailing twelve-month figure through Sep 2025 stood at $908000.0 (down 97.88% YoY), and the FY2022 full-year result was $418000.0, down 69.69% from the prior year.
- Total Non-Current Liabilities steadied at $897000.0 in Q1 2026 per ATAI's latest filing.
- In the past five years, Total Non-Current Liabilities ranged from a high of $42.8 million in Q3 2024 to a low of $412000.0 in Q1 2023.
- A 5-year average of $14.1 million and a median of $910000.0 in 2025 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities jumped 9023.54% in 2024 and slumped 97.88% in 2025, its largest moves.
- Tracing ATAI's Total Non-Current Liabilities over 5 years: stood at $1.4 million in 2021, then sank by 69.69% to $418000.0 in 2022, then surged by 7235.65% to $30.7 million in 2023, then surged by 39.66% to $42.8 million in 2024, then tumbled by 97.88% to $908000.0 in 2025.
- Business Quant data shows ATAI's Total Non-Current Liabilities at $908000.0 in Q3 2025, $910000.0 in Q2 2025, and $820000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 4.45 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.28 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.98 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 949,738.67 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.87 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 7.32 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 40.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 746.94 Mn |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - | 908,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 897,000.00 |
| Sep 30, 2025 | 908,000.00 |
| Jun 30, 2025 | 910,000.00 |
| Mar 31, 2025 | 820,000.00 |
| Sep 30, 2024 | 42.83 Mn |
| Jun 30, 2024 | 38.99 Mn |
| Mar 31, 2024 | 37.59 Mn |
| Jun 30, 2023 | 30.66 Mn |
| Mar 31, 2023 | 412,000.00 |
| Dec 31, 2022 | 418,000.00 |
| Sep 30, 2022 | 425,000.00 |
| Dec 31, 2021 | 1.38 Mn |
| Dec 31, 2020 | 48,000.00 |